To test the efficacy of 6-month LGG compared to placebo in treating Alcoholic Use Disorder
(AUD) and liver injury in Alcoholic Hepatitis (AH). And to evaluate the effects of LGG
treatment compared to placebo on therapeutic-mechanistic markers of the gut-brain axis and
pro-inflammatory activity in patients with AUD and moderate AH
Phase:
Phase 2
Details
Lead Sponsor:
University of Louisville
Collaborator:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)